Search - tctmd.com

Displaying 221 - 231 of 231

Sort: Relevancy | Date

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

News Industry News

Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent

October 18, 2011

News Industry News

Boston Scientific's WallFlex® Biliary RX Stent Receives Canadian Approval for Expanded Indication

August 09, 2011

News Daily News

SOURCE Registry Data Published: TAVI Stays Strong at 1 Year

Caitlin E. Cox

July 15, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Jason Kahn

June 06, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn

April 21, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Industry News

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

January 02, 2011

Advertisement

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent

Boston Scientific's WallFlex® Biliary RX Stent Receives Canadian Approval for Expanded Indication

SOURCE Registry Data Published: TAVI Stays Strong at 1 Year

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content